I want to if I could real quick address Atlantic >> taking profits. What profits. I totally get that.>> Yeah, >> you're not unless unless you got attracted to this market at the bottom, chances are you bought as it was exploding to the upside. which means you need to wait around long enough for the new cycle to come around and new all-time highs. If you don't have the patience to do that, then you're going to remain in that context of taking profits.What profits. There are no profits to take. And that's tru ...

Taking profits and moving towards cash isn't a bad strategy.It's one of the best ways to compound your returns.If you're uncomfortable holding your #Altcoin, it's a wise decision to scale off and go towards a safe place. ...

Investment Strategy - The market sentiment suggests a reluctance to realize profits, favoring continuous portfolio growth [1] - A sell-high and buy-low strategy is advocated [1] - Arrogance and greed are identified as potential risks to investment success [1]

Core Insights - Renaissance Technologies is recognized as the most successful hedge fund, with its Medallion Fund achieving annualized after-fees returns of 39% from 1998 to 2021 [1] - Despite the passing of its founder Jim Simons in 2024, Renaissance's investment strategies and quarterly moves continue to attract attention from investors [1] Group 1: Palantir Technologies - Palantir remains the largest holding in Renaissance's portfolio, despite a 17% reduction in shares during Q2 [2][3] - The stock experienced a significant increase of approximately 61% from March 31 to June 30 [2] - Over the past 52 weeks, Palantir's stock has surged nearly 400%, with a forward P/E ratio exceeding 200x [3] Group 2: Robinhood Markets - Robinhood is also among the top five holdings, with a 31% reduction in shares in Q2, while the stock rose about 125% during the same period [5][6] - The stock reached an all-time high forward P/E of around 71x in early June but has since decreased to approximately 54x [6] Group 3: UnitedHealth Group - Renaissance initiated a new position in UnitedHealth Group, purchasing approximately 1.35 million shares, following Berkshire Hathaway's significant investment [7][8] - The stock trades about 15% higher than its lowest level in Q2, indicating potential value for investors [9] Group 4: NVIDIA - Renaissance made a substantial increase in its position in NVIDIA, raising shares from around 1.1 million in Q1 to 7.4 million in Q2, marking a 584% increase [10] - The decision to increase holdings may have been influenced by a reassessment of previous fears related to DeepSeek [12] - The average closing price of NVIDIA remained stable between Q1 and Q2, suggesting that price action was not the primary factor for the dramatic change in position [11] Group 5: Investment Strategies - Renaissance's investment moves highlight two strategies: taking profits on significant winners and selectively dip-buying during downturns in dominant industry players [13]